URMC Related Haplo-identical Donor BMT

NCT02660281 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Hematological Disease
Immune Deficiencies
Solid Tumors
Myelofibrosis
Multiple Myeloma
Lymphoma

Interventions

RADIATION: Total Body Irradiation 1200 cGy
DRUG: Fludarabine
DRUG: Pre-Stem Cell Infusion Cyclophosphamide
DRUG: Pre-Stem Cell Infusion Mesna
DRUG: Busulfan
DRUG: Melphalan
PROCEDURE: Stem Cell Infusion
DRUG: Post-Stem Cell Infusion Cyclophosphamide
DRUG: Post-Stem Cell Infusion Mesna
DRUG: Thiotepa

Sponsor

University of Rochester